- Home
- LVRO vs TVRD Comparison
LVRO vs TVRD Comparison
Compare LVRO & TVRD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LVRO
- TVRD
- Stock Information
- Founded
- LVRO 2017
- TVRD 2017
- Country
- LVRO Brazil
- TVRD United States
- Employees
- LVRO N/A
- TVRD N/A
- Industry
- LVRO Blank Checks
- TVRD Biotechnology: Pharmaceutical Preparations
- Sector
- LVRO Finance
- TVRD Health Care
- Exchange
- LVRO Nasdaq
- TVRD Nasdaq
- Market Cap
- LVRO 297.4M
- TVRD 246.5M
- IPO Year
- LVRO N/A
- TVRD N/A
- Fundamental
- Price
- LVRO $2.60
- TVRD $29.41
- Analyst Decision
- LVRO Buy
- TVRD Strong Buy
- Analyst Count
- LVRO 3
- TVRD 2
- Target Price
- LVRO $4.00
- TVRD $52.00
- AVG Volume (30 Days)
- LVRO 8.1K
- TVRD 48.4K
- Earning Date
- LVRO 06-10-2025
- TVRD 05-13-2025
- Dividend Yield
- LVRO N/A
- TVRD N/A
- EPS Growth
- LVRO N/A
- TVRD N/A
- EPS
- LVRO N/A
- TVRD N/A
- Revenue
- LVRO $1,667,345,189.00
- TVRD N/A
- Revenue This Year
- LVRO N/A
- TVRD N/A
- Revenue Next Year
- LVRO $13.35
- TVRD N/A
- P/E Ratio
- LVRO N/A
- TVRD N/A
- Revenue Growth
- LVRO N/A
- TVRD N/A
- 52 Week Low
- LVRO $2.10
- TVRD $8.13
- 52 Week High
- LVRO $7.00
- TVRD $34.31
- Technical
- Relative Strength Index (RSI)
- LVRO 49.19
- TVRD N/A
- Support Level
- LVRO $2.10
- TVRD N/A
- Resistance Level
- LVRO $2.61
- TVRD N/A
- Average True Range (ATR)
- LVRO 0.21
- TVRD 0.00
- MACD
- LVRO 0.03
- TVRD 0.00
- Stochastic Oscillator
- LVRO 56.82
- TVRD 0.00
About LVRO Lavoro Limited
Lavoro Ltd operates in the agricultural inputs retail market, with operations spread across Brazil and Colombia, and an emergent agricultural input trading company in Uruguay. The reportable segments of the company include the Brazil Ag Retail, which comprises companies dedicated to the distribution of agricultural inputs such as crop protection, seeds, fertilizers and specialty products, in Brazil; Latam Ag Retail, which includes companies dedicated to the distribution of agricultural inputs outside Brazil (predominantly in Colombia); and the Crop Care. A substantial part of the company's overall revenue is generated from its Brazil Ag Retail segment.
About TVRD Tvardi Therapeutics Inc. Common Stock
Tvardi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development of novel, oral small molecule therapies targeting STAT3 to treat fibrosis-driven diseases. Its key product candidate, TTI-101, is in Phase 2 clinical development for the treatment of idiopathic pulmonary fibrosis (IPF), and hepatocellular carcinoma (HCC). Its second product candidate, TTI-109, is structurally related to, yet chemically distinct from, TTI-101 and is designed to enhance the ability to target STAT3.